How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Have some old notes in another OneNote but want to merge them into a new notebook related to those notes without copying and pasting the notes in the new notebook. There is a feature in OneNote called ...

Jonas Elmerraji is editor of the Rhino Stock Report, a GARP investment newsletter. He launched the "Young Investor" category for Investopedia. Andy Smith is a Certified Financial Planner (CFP®), ...